Vivek Kaul, MD

Advanced GI endoscopy
University of Rochester Medical Center, United States

Presentation(s):

• P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study

  Friday, March 24, 2023
  1:21 PM – 1:26 PM

  Disclosure information not submitted.